z-logo
open-access-imgOpen Access
Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies
Author(s) -
James F. Donohue,
Thomas Goodin,
Robert Tosiello,
Alistair Wheeler
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/qhkt-0s64
Subject(s) - glycopyrrolate , nebulizer , medicine , obstructive lung disease , phase (matter) , lung , anesthesia , atropine , pulmonary disease , chemistry , organic chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom